Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Does Dapagliflozin Augment The Favorable Adaptation To Endurance Exercise Training?

NCT02371187 is registered in ClinicalTrials.gov with Christopher Bell as lead sponsor.

NCT NCT02371187
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02371187 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Does Dapagliflozin Augment The Favorable Adaptation To Endurance Exercise Training?
Lead sponsor
Christopher Bell
Phase
Phase 2
Overall status
Completed
Start date
June 30, 2015
Completion date
January 31, 2018
Enrollment
37 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

physical activity